(Q48717382)

14 February 2018

title

Ubiquitinated granular structures and initial neurofibrillary changes in the human brain. (English)

1 reference

14 February 2018

main subject

protein ubiquitination

1 reference

García Gil ML

1

1 reference

14 February 2018

Morán MA

series ordinal

2

1 reference

14 February 2018

Gómez-Ramos P

series ordinal

3

1 reference

14 February 2018

publication date

1 November 2001

1 reference

14 February 2018

Journal of the Neurological Sciences

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

14 February 2018

volume

192

1 reference

14 February 2018

issue

1-2

1 reference

14 February 2018

page(s)

27-34

1 reference

14 February 2018

The ubiquitin-proteasome pathway: on protein death and cell life

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Ubiquitin in health and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Ubiquitin in homeostasis, development and disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Ubiquitin is a component of paired helical filaments in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodie

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Neuropathological stageing of Alzheimer-related changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

An immunohistochemical study of centenarian brains: a comparison.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Suppression of cathepsins B and L causes a proliferation of lysosomes and the formation of meganeurites in hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Characterization of tau protein present in microtubules and paired helical filaments of Alzheimer's disease patient's brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Lysosomal protease inhibitors induce meganeurites and tangle-like structures in entorhinohippocampal regions vulnerable to Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and Ca2+ influx in cultured hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer brains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

Cell biology of synaptic plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900587-1

10.1016/S0022-510X(01)00587-1

7 January 2021

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018